Search results for "Hepatocellular carcinoma"
Case reports published on gastroenterology, hepatology topics
Reports on hepatocellular carcinoma at initial cirrhosis diagnosis, asymptomatic celiac disease, and massive splenomegaly were published in the past month.
https://gastroenterology.acponline.org/archives/2023/02/24/12.htm
24 Feb 2023
Spotlight on statins and chronic liver disease
Recent studies found associations between statin use and decreased risks of severe liver disease and mortality in patients with chronic liver disease.
https://gastroenterology.acponline.org/archives/2023/05/26/5.htm
26 May 2023
Noninvasive methods as good as biopsy for NAFLD prognosis, meta-analysis finds
An analysis of patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) compared the prognostic value of liver stiffness measured by vibration-controlled transient elastography, fibrosis-4 index, and NAFLD fibrosis score.
https://gastroenterology.acponline.org/archives/2023/06/23/1.htm
23 Jun 2023
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
New guidance on diagnosis, management of acute hepatic porphyrias
These genetic errors of heme metabolism, although rare, appear to be more common than previously thought, and recent treatment advances have improved the outlook for patients with the diagnoses, according to the American Gastroenterological Association.
https://gastroenterology.acponline.org/archives/2023/01/27/1.htm
27 Jan 2023
Spotlight on mortality trends in liver disease
One study looked at 10-year U.S. mortality trends related to chronic liver diseases, while another assessed mortality from cirrhosis and liver cancer in the U.S. from 1999 to 2016.
https://gastroenterology.acponline.org/archives/2018/07/27/5.htm
27 Jul 2018
Daily aspirin may reduce risk of hepatitis-related liver cancer
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
https://gastroenterology.acponline.org/archives/2019/03/22/1.htm
22 Mar 2019
MKSAP Quiz: Management of HBV infection
This month's quiz asks readers to determine the most appropriate next step in management of a 29-year-old woman with hepatitis B virus (HBV) infection and normal liver enzyme levels.
https://gastroenterology.acponline.org/archives/2021/04/23/4.htm
23 Apr 2021
Spotlight on cirrhosis
Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic steatohepatitis-associated cirrhosis.
https://gastroenterology.acponline.org/archives/2017/02/24/5.htm
24 Feb 2017
Liver cancer diagnosis delayed in almost half of veterans with cirrhosis
Failure to follow guidelines, diagnostic imaging without alpha-fetoprotein measurement, and diagnosis from an incidental finding were all associated with a delay of more than 60 days between a red flag for hepatocellular carcinoma and a diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/07/24/2.htm
24 Jul 2020